Fiscal First Quarter 2026 Financial Highlights • Revenue was $162.1 million compared to $135.5 million in the first quarter of the fiscal year ended January 31, 2025, up 19.6% year-over year, driven primarily by new customers, upsells, and renewals. • Subscription revenue in the quarter was $154.9 million compared to $130.1 million in the first quarter of the fiscal year ended January 31, 2025, and professional services and other revenue was $7.2 million compared to $5.4 million in the first quarter of the ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 4, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33608 lululemon athletica inc. (Exact name of registrant as specified in its charter) (State or other jurisdictio ...

Financial Performance - Net sales for the nine months ended April 30, 2025, increased to $360.36 million, up from $323.89 million in the same period of 2024, representing a growth of 11.3%[13] - Gross profit for the nine months ended April 30, 2025, was $108.25 million, compared to $92.07 million in 2024, reflecting a gross margin increase from 28.5% to 30.0%[13] - Net income for the nine months ended April 30, 2025, rose to $40.94 million, a 32.5% increase from $30.90 million in 2024[13] - Earnings per share for basic common stock increased to $3.03 for the nine months ended April 30, 2025, compared to $2.29 in 2024, marking a growth of 32.3%[13] - Operating income for the nine months ended April 30, 2025, was $52.58 million, up from $38.75 million in 2024, reflecting a growth of 35.7%[13] - The company reported a total comprehensive income of $40.92 million for the nine months ended April 30, 2025, compared to $30.85 million in 2024, an increase of 32.7%[16] - Net income for the nine months ended April 30, 2025, was $40,941,000, an increase from $30,901,000 in the same period of 2024, representing a growth of approximately 32.9%[27] - Net income for the nine months ended April 30, 2025, was $40,941,000, compared to $30,901,000 for the same period in 2024, marking a 32.5% increase[87] Assets and Liabilities - Total assets as of April 30, 2025, were $369.54 million, an increase from $354.61 million as of July 31, 2024[10] - Total liabilities decreased to $122.68 million as of April 30, 2025, down from $144.02 million as of July 31, 2024, indicating a reduction of 14.8%[12] - The company's total assets increased to $369,543,000 as of April 30, 2025, from $354,605,000 as of July 31, 2024, reflecting a growth of 4.2%[85] - Retained earnings increased to $266.89 million as of April 30, 2025, compared to $232.25 million as of July 31, 2024, reflecting a growth of approximately 14.9%[12] Cash Flow and Investments - Cash provided by operating activities for the nine months ended April 30, 2025, was $54,988,000, compared to $36,929,000 for the same period in 2024, indicating a year-over-year increase of about 48.9%[27] - Capital expenditures for the nine months ended April 30, 2025, were $24,483,000, slightly higher than $23,717,000 in the same period of 2024[27] - The ending balance of cash and cash equivalents as of April 30, 2025, was $36,475,000, down from $46,821,000 at the end of the same period in 2024[27] - The company recorded a loss on impairment of patent applications amounting to $48,000 for the nine months ended April 30, 2025, with no such loss reported in 2024[27] Dividends - The company declared dividends of $0.465 per share for common stock and $0.350 per share for Class B stock for the nine months ended April 30, 2025, compared to $0.435 and $0.327 respectively in 2024[13] - The company declared dividends totaling $6,290,000 for the nine months ended April 30, 2025, compared to $5,848,000 in 2024, reflecting an increase of approximately 7.5%[27] - The company declared dividends of $0.1550 per share for basic common stock, up from $0.1450 in the previous year, marking an increase of about 3.4%[19] Stock and Shares - The average shares outstanding for diluted common stock increased to 13.87 million for the nine months ended April 30, 2025, from 13.70 million in 2024[13] - The stock split increased the number of authorized shares of Common Stock from 15 million to 30 million[36] - As of April 30, 2025, there were 1,075,528 shares of Common Stock or Class B Stock available for future grants under the 2006 Plan, which allows a total of 3,439,000 shares to be granted[88] Accounting and Compliance - The company has not adopted any new accounting pronouncements in the period[57] - The Financial Accounting Standards Board issued ASU No. 2023-07, requiring enhanced disclosures about significant segment expenses, effective for fiscal years beginning after December 15, 2023[54] - The company is currently evaluating the impact of recently issued accounting standards on its disclosures, including ASU No. 2023-07 and ASU No. 2023-09[54][55] Segment Performance - For the nine months ended April 30, 2025, net sales for the Business to Business Products Group were $134,509,000, up 20.5% from $111,591,000 in 2024[87] - The Retail and Wholesale Products Group reported net sales of $225,851,000 for the nine months ended April 30, 2025, an increase of 6.4% from $212,294,000 in 2024[87] - Operating income for the Business to Business Products Group increased to $44.8 million for the nine months ended April 30, 2025, compared to $32.7 million in 2024[87] Other Financial Metrics - Total inventories as of April 30, 2025, amounted to $56,531,000, a 4.3% increase from $54,236,000 as of July 31, 2024[62] - Cash equivalents increased to $6,900,000 as of April 30, 2025, compared to $3,000,000 as of July 31, 2024[63] - The estimated fair value of debt was $41,100,000 as of April 30, 2025, down from $51,100,000 as of July 31, 2024[65] - Accrued expenses totaled $37,207,000 as of April 30, 2025, a decrease of 15.4% from $44,016,000 as of July 31, 2024[71]

Exhibit 99.1 LULULEMON ATHLETICA INC. ANNOUNCES FIRST QUARTER FISCAL 2025 RESULTS Revenue increased 7% to $2.4 billion, or increased 8% on a constant dollar basis Comparable sales increased 1% Diluted EPS of $2.60 Vancouver, British Columbia – June 5, 2025 – lululemon athletica inc. (NASDAQ:LULU) today announced financial results for the first quarter of fiscal 2025, which ended on May 4, 2025. Calvin McDonald, Chief Executive Officer, stated: "In the first quarter, we achieved growth across channels, categ ...

FOR IMMEDIATE RELEASE: June 5, 2025 Petco Health + Wellness Company, Inc. Reports First Quarter 2025 Exhibit 99.1 Contacts: Investor Relations Media Relations Tina Romani Lisa Stark investorrelations@petco.com Lisa.stark@petco.com Financial Results Reaffirms Fiscal 2025 Net Sales and Earnings Outlook* San Diego, June 5, 2025 – Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) today announced its first quarter 2025 financial results. Q1 2025 Overview "We are pleased to deliver first quarter earnings res ...

Exhibit 99.1 "Our performance throughout the 2024/2025 North American ski season reflects the strength of our advance commitment strategy, strong destination guest spending, and the impact of our resource efficiency transformation plan. The Company achieved 3% growth in Resort Reported EBITDA year-to-date despite total skier visits declining 3% across our North American destination mountain resorts and regional ski areas from the beginning of the ski season through April 30, 2025. North American visitation ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40528 Sprinklr, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware (State or other Jurisdiction of Incorporat ...

Financial Performance - Gross transaction volume (GTV) for Q1 2026 reached $17.7 billion, a year-over-year growth of 22% compared to $14.5 billion in Q1 2025[3] - Total revenue for Q1 2026 was $215.7 million, reflecting a 27% increase from $170.3 million in Q1 2025[3] - Non-GAAP income from operations for Q1 2026 was $16.2 million, with a non-GAAP operating margin of 7.5%, up from 1.9% in Q1 2025[3] - Platform revenue for Q1 2026 was $208 million, showing a consistent year-over-year growth of 27%[3] - The company reported a GAAP loss from operations of $49.5 million in Q1 2026, an improvement from a loss of $53.4 million in Q1 2025[3] - Non-GAAP income from operations for Q2 2026 is projected to be between $17 million and $18 million, and for the full fiscal year 2026 between $54 million and $59 million[4] - The company expects total revenue for Q2 2026 to be between $228 million and $230 million, and for the full fiscal year 2026 to be between $910 million and $920 million[4] Cash Flow and Expenses - Net cash used in operating activities decreased to $14.6 million in Q1 2026 from $19.2 million in Q1 2025[3] - Cash used in operating activities for Q2 2025 was $14,570,000, an improvement from $19,224,000 in Q2 2024[18] - Net cash used in investing activities was $7,764,000 in Q2 2025, compared to $6,597,000 in Q2 2024[18] - The company reported a net decrease in cash, cash equivalents, and restricted cash of $21,954,000 for the period, down from $30,929,000 in the previous year[18] - The ending cash balance for the period was $420,892,000, compared to $117,934,000 at the end of the same period in 2024[18] Profitability Metrics - Net dollar retention rate remains above 110%, indicating strong customer retention and expansion[3] - Non-GAAP net income reached $17,897,000 in Q2 2025, up from $212,000 in Q2 2024, marking a substantial increase in profitability[32] - Non-GAAP net income per share (diluted) was $0.18 for Q2 2025, while the GAAP net loss per share (diluted) was $(0.51)[33] - Free cash flow for Q2 2025 was $(22,334,000), slightly improved from $(24,637,000) in Q2 2024, reflecting better cash management[34] Operating Expenses - Non-GAAP sales and marketing expense was $56,375,000 in Q2 2025, up from $44,635,000 in Q2 2024, indicating a 26.4% increase[27] - Non-GAAP research and development expense increased to $55,198,000 in Q2 2025 from $46,386,000 in Q2 2024, a rise of 19.0%[28] - Non-GAAP general and administrative expense was $30,974,000 in Q2 2025, compared to $24,406,000 in Q2 2024, marking a 27.0% increase[29] - Stock-based compensation expense increased to $33,260,000 in Q2 2025 from $20,572,000 in Q2 2024, indicating higher costs associated with employee compensation[32] Operational Efficiency - Non-GAAP operating margin improved to 7.5% in Q2 2025, compared to 1.9% in Q2 2024, indicating a positive trend in operational efficiency[31] - GAAP operating margin improved to (23.0)% in Q2 2025 from (31.4)% in Q2 2024, reflecting enhanced operational performance[31] - The loss on operating lease assets decreased to $8,032,000 in Q2 2025 from $20,081,000 in Q2 2024, indicating better asset management[30]

DENVER, CO – June 5, 2025 – Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (the "Company" or "CPH"), a leading provider of concrete pumping and waste management services in the U.S. and U.K., reported financial results for the second quarter ended April 30, 2025. Second Quarter Fiscal Year 2025 Summary vs. Second Quarter of Fiscal Year 2024 (where applicable) Management Commentary Exhibit 99.1 Concrete Pumping Holdings Reports Second Quarter Fiscal Year 2025 Results - Announces $15 Million Increase to Share ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File No. 001-35996 VIVOSIM LABS, INC. (Exact name of registrant as specified in its charter) | Delaware 27-1488943 | | | --- | --- | | (State or other j ...